Clinical trial
Comparison of Adalimumab and Infliximab Treatment of Rheumatoid Arthritis
NCT00216177 · Hvidovre University Hospital, Other · Unknown status
Key facts
| NCT number | NCT00216177 |
|---|---|
| Title | Comparison of Adalimumab and Infliximab Treatment of Rheumatoid Arthritis |
| Official title | Randomised, Multicenter, Open-label, Parallel-group Study Comparing Adalimumab 40 mg s.c. Eow Versus Infliximab 3 mg/kg i.v. Every 6 Weeks in Rheumatoid Arthritis Patients With Unsustainable Clinical Response to Infliximab 3 mg/kg Every 8 Weeks |
| Lead sponsor | Hvidovre University Hospital, Other |
| Collaborators | University Hospital, Gentofte, Copenhagen |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | Infliximab, Adalimumab |
| Enrollment | 112 |
| Start date | Sep 1, 2005 |
| Primary completion | Jan 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Sep 22, 2005 |
| Last update posted | Aug 18, 2009 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: